Increased phosphorylation of ERK-1/2 has been observed with terminal differentiation in various cell lines [18, 60] and sustained ERK-MAPK pathway activation has been reported to induce growth arrest in epidermoid carcinoma cells [19]. Here, MAPK3 is linked to squamous cell carcinoma.